Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 1096 AL 1110

Learning by failing: ideas and concepts to tackle γ-secretases in Alzheimer's disease and beyond

De Strooper B, Chávez Gutiérrez L.

Annu Rev Pharmacol Toxicol. 2015;55:419-37. doi: 10.1146/annurev-pharmtox-010814-124309. Epub 2014 Oct 1.

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

Newport MT, VanItallie TB, Kashiwaya Y, King MT, Veech RL.

Alzheimers Dement. 2015 Jan;11(1):99-103. doi: 10.1016/j.jalz.2014.01.006. Epub 2014 Oct 7.

An overview of various mammalian models to study chronic copper intoxication associated Alzheimer's disease like pathology

Pal A, Prasad R.

Biometals. 2015 Feb;28(1):1-9. doi: 10.1007/s10534-014-9799-3. Epub 2014 Oct 12.

Endoplasmic reticulum stress as a novel neuronal mediator in Alzheimer's disease

Huang HC, Tang D, Lu SY, Jiang ZF.

Neurol Res. 2015 Apr;37(4):366-74. doi: 10.1179/1743132814Y.0000000448. Epub 2014 Oct 13.

Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment

Pasinetti GM, Wang J, Ho L, Zhao W, Dubner L.

Biochim Biophys Acta. 2015 Jun;1852(6):1202-8. doi: 10.1016/j.bbadis.2014.10.006. Epub 2014 Oct 12.

Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights

Mehta DC, Short JL, Hilmer SN, Nicolazzo JA.

Pharm Res. 2015 Mar;32(3):819-39. doi: 10.1007/s11095-014-1522-0. Epub 2014 Oct 16.

Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease

Baddeley TC, McCaffrey J, Storey JM, Cheung JK, Melis V, Horsley D, Harrington CR, Wischik CM.

J Pharmacol Exp Ther. 2015 Jan;352(1):110-8. doi: 10.1124/jpet.114.219352. Epub 2014 Oct 15.

Dependence scale for Alzheimer's disease: relationship with other clinical indicators and psychometric properties

Garre-Olmo J, Vilalta-Franch J, Calvó-Perxas L, Monserrat-Vila S, López-Pousa S; CoDep-AD Study Group.

J Geriatr Psychiatry Neurol. 2015 Jun;28(2):117-25. doi: 10.1177/0891988714554711. Epub 2014 Oct 20.

Hypertension and Alzheimer disease: another brick in the wall of awareness

Thorin E.

Hypertension. 2015 Jan;65(1):36-8. doi: 10.1161/HYPERTENSIONAHA.114.04257. Epub 2014 Oct 20.

Aβ Influences Cytoskeletal Signaling Cascades with Consequences to Alzheimer's Disease

Henriques AG, Oliveira JM, Carvalho LP, da Cruz E Silva OAB.

Mol Neurobiol. 2015 Dec;52(3):1391-1407. doi: 10.1007/s12035-014-8913-4. Epub 2014 Oct 26.

Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain

Darbà J, Kaskens L, Lacey L.

Eur J Health Econ. 2015 Nov;16(8):895-905. doi: 10.1007/s10198-014-0642-0. Epub 2014 Oct 28.

From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration

Zhao Y, Gong CX.

Cell Mol Neurobiol. 2015 Jan;35(1):101-10. doi: 10.1007/s10571-014-0127-9. Epub 2014 Oct 29.

Effect of rivastigmine or memantine add-on therapy is affected by butyrylcholinesterase genotype in patients with probable Alzheimer's disease

Han HJ, Kwon JC, Kim JE, Kim SG, Park JM, Park KW, Park KC, Park KH, Moon SY, Seo SW, Choi SH, Cho SJ.

Eur Neurol. 2015;73(1-2):23-8. doi: 10.1159/000366198. Epub 2014 Nov 1.

ATF4: a Novel Potential Therapeutic Target for Alzheimer's Disease

Wei N, Zhu LQ, Liu D.

Mol Neurobiol. 2015 Dec;52(3):1765-1770. doi: 10.1007/s12035-014-8970-8. Epub 2014 Nov 9.

Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease

Cagnin A, Cester A, Costa B, Ermani M, Gabelli C, Gambina G; SWITCH study working group.

Neurol Sci. 2015 Mar;36(3):457-63. doi: 10.1007/s10072-014-2002-3. Epub 2014 Nov 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias